Authors:
GUPTA E
MICK R
RAMIREZ J
WANG XL
LESTINGI TM
VOKES EE
RATAIN MJ
Citation: E. Gupta et al., PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF THE TOPOISOMERASE INHIBITOR IRINOTECAN IN CANCER-PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1502-1510
Authors:
MICK R
VOKES EE
LESTINGI TM
GRAYSTERN W
FLEMING GF
SCHILSKY RL
RATAIN MJ
Citation: R. Mick et al., ETOPOSIDE COMBINED WITH INTERFERON ALFA-2B - NOVEL EXPLOITATION OF ESTABLISHED ETOPOSIDE PHARMACOKINETICS AND PHARMACODYNAMICS, Clinical pharmacology and therapeutics, 59(3), 1996, pp. 349-359
Citation: Nj. Vogelzang et al., PHASE-I STUDY OF IMMUNOTHERAPY OF METASTATIC RENAL-CELL CARCINOMA BY DIRECT GENE-TRANSFER INTO METASTATIC LESIONS, Human gene therapy, 5(11), 1994, pp. 1357-1370
Authors:
GUPTA E
LESTINGI TM
MICK R
RAMIREZ J
VOKES EE
RATAIN MJ
Citation: E. Gupta et al., RELATIONSHIP OF CPT-11 INDUCED DIARRHEA TO GLUCURONIDATION OF ITS METABOLITE SN-38, Clinical research, 42(3), 1994, pp. 10000394-10000394
Authors:
GUPTA F
LESTINGI TM
MICK R
RAMIREZ J
VOKES EE
RATAIN MJ
Citation: F. Gupta et al., METABOLIC-FATE OF IRINOTECAN IN HUMANS - CORRELATION OF GLUCURONIDATION WITH DIARRHEA, Cancer research, 54(14), 1994, pp. 3723-3725